McGraw-Hills AccessMedicine

FDA Approves New Protease Inhibitor for Salavage Therapy: Darunavir (TMC114)

Listen Later
Harrison's Online Update: FDA Approves New Protease Inhibitor for Salavage Therapy: Darunavir (TMC114)
...more
View all episodesView all episodes
Download on the App Store
McGraw-Hills AccessMedicineBy McGraw-Hill
  • 3.6
  • 3.6
  • 3.6
  • 3.6
  • 3.6

3.6

7 ratings